Why U.S. Regulators Are Cracking Down on Private Equity Investments in the Healthcare Sector
August 11, 2025
Global Competition Review – Americas Antitrust Review 2026
Axinn managing partner Jeny Maier, counsel Monica Smith, and associate Leandra Ipiña co-authored a chapter in Global Competition Review’s Americas Antitrust Review 2026 titled “Why U.S. Regulators Are Cracking Down on Private Equity Investments in the Healthcare Sector.”
Click here to access the chapter.
Accreditation: This article was first published on Global Competition Review in August 2025; for further in-depth analysis, please visit GCR - Americas Antitrust Review 2026
To subscribe to our publications, click here.
Featured Insights
Featured Insights
The Empty Chair in Antitrust Conspiracy Cases
Webinar
Antitrust
2026 Concurrences International Mergers Conference
Speaking Engagement
Antitrust
USC Gould/Analysis Group Global Competition Law Thought Leadership Conference
Speaking Engagement
Antitrust
17th ACI Summit on Biosimilars & Innovator Biologics
Speaking Engagement
Intellectual Property
GCR Live: Europe 2026
Speaking Engagement
Antitrust
Fixing “Litigate the Fix”: Insights from the FTC’s Workshop
Axinn Viewpoints
Antitrust
20th Annual IBA Competition Mid-Year Conference
Speaking Engagement
Antitrust
Axinn Recognized in 2026 IAM Patent 1000 for Patent Litigation Excellence
Awards & Recognitions
Intellectual Property
Axinn Partners Named to Lawdragon 500 Leading Global Litigators 2026
News
Litigation & Trials
Turning Up the Heat: Federal Circuit Sets the Temperature for pH Measurements in Precedential Opinion
Axinn Viewpoints
Intellectual Property